Compare Vaxcyte Inc. Common Stock (PCVX) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs United States Oil ETF — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while United States Oil ETF trades at $151.88 (market cap $1.86B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 5.7× United States Oil ETF's market cap, and United States Oil ETF is more actively traded (3,642,169 versus 2,644,694). Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and United States Oil ETF for 21 Days on average.
| PCVX | USO | |
|---|---|---|
Market Cap | $10.51B | $1.86B |
Volume | 2,644,694 | 3,642,169 |
Sector | Health | — |
52-Week High | $73.82 | $161.86 |
52-Week Low | $40.32 | $66.17 |
Typical Hold Time | 0 Days | 21 Days |
Enterprise Value | $9.14B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
USO trades at $153.09, up 1.36% with a bullish technical signal supported by moving averages. Recent Middle East tensions and OPEC+ production decisions create volatility in oil markets, though G-7 reserve releases aim to curb prices. The stock shows strong technical momentum with key resistance at $154.
Outlook remains volatile with geopolitical risks balanced against supply interventions. Investment opportunity exists for traders capitalizing on oil price swings, though regulatory and operational risks persist. The stock's performance remains tightly linked to crude oil price movements and global supply dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
